EUVIMEDEUVIMED entdecken
Open Access

Precarious hope: Ethical considerations for offering experimental fetal therapies outside of research after initial studies in humans

Saskia Hendriks, Janyne Althaus, Meredith A Atkinson, Ahmet A Baschat, Benjamin E Berkman, Christine Grady, David Wasserman, David Wendler, Jena L Miller

Prenatal Diagnosis · 2024-02 · 44 (2) · 180-186

DOI: 10.1002/pd.6474 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Prenatal Diagnosis, online erschienen am 09.12.2023. Verfasst von Saskia Hendriks und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioethics, NIH Clinical Center, Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: Prenatal Care, Fetal Therapies. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, Intramural NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Risks and benefits of experimental fetal therapies can remain uncertain after initial clinical studies, especially long‐term effects. Nevertheless, pregnant individuals may request them, hoping to benefit their future child. Guidance about offering experimental fetal therapies outside research (as “innovative therapy”) is limited, despite their ethical complexity. We propose points for clinicians and reviewers to consider when deciding whether and how to offer experimental fetal therapies as innovative therapies after initial clinical studies.

Method

We used conceptual analysis and a current case to develop points for consideration, grounded in broader debates on innovative therapy and the unique challenges associated with experimental fetal therapies.

Results

Clinicians should evaluate whether offering experimental fetal therapies as innovative therapy is appropriate for a pregnant individual and their fetus. The anticipated risk‐benefit ratio for the fetus should be favorable. For the pregnant individual, risks may outweigh benefits, within reasonable limits. Medical resources should be sufficient to ensure appropriate care. Clinicians should support pregnant individuals in making informed choices. Clinicians offering innovative therapies with more than minimal risk should collect and report data on outcomes. Independent review should take place.

Conclusion

Considering these points may advance the interests of fetuses, future children, and their families.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prenatal CareFetal TherapiesPregnancyFemaleChildHumansFetusRisk AssessmentTherapies, Investigational

Autor:innen und Institutionen

  • Department of Bioethics, NIH Clinical Center, Bethesda, Maryland, USA.
  • Department of Obstetrics, Gynecology and Reproductive Sciences, University of Maryland, Baltimore, Maryland, USA.
  • Department of Pediatrics, Division of Nephrology, Johns Hopkins University, Baltimore, Maryland, USA.
  • Department of Gynecology and Obstetrics, Center for Fetal Therapy, Johns Hopkins University, Baltimore, Maryland, USA.
  • National Human Genome Research Institute, Bethesda, Maryland, USA.

Förderung

  • NICHD NIH HHS
  • Intramural NIH HHS
  • NIH HHS
  • National Institutes of Health
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development

Zitieren

APA

Hendriks, S., Althaus, J., Atkinson, M. A., Baschat, A. A., Berkman, B. E., Grady, C., Wasserman, D., Wendler, D., & Miller, J. L. (2024). Precarious hope: Ethical considerations for offering experimental fetal therapies outside of research after initial studies in humans. Prenatal Diagnosis, 44(2), 180-186. https://doi.org/10.1002/pd.6474

Vancouver

Hendriks S, Althaus J, Atkinson MA, Baschat AA, Berkman BE, Grady C, et al. Precarious hope: Ethical considerations for offering experimental fetal therapies outside of research after initial studies in humans. Prenatal Diagnosis. 2024;44(2):180-186. doi:10.1002/pd.6474

BibTeX
@article{Hendriks2024,
  author = {Hendriks, Saskia and Althaus, Janyne and Atkinson, Meredith A and Baschat, Ahmet A and Berkman, Benjamin E and Grady, Christine and Wasserman, David and Wendler, David and Miller, Jena L},
  title = {Precarious hope: Ethical considerations for offering experimental fetal therapies outside of research after initial studies in humans},
  journal = {Prenatal Diagnosis},
  year = {2024},
  volume = {44},
  number = {2},
  pages = {180--186},
  doi = {10.1002/pd.6474}
}
Kostenlos starten →